Verona Pharma plc (VRNA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
VRNA currently has 685M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 5.63% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Aug 06, 2025 |
10-Q filing | 685.2M shares outstanding |
690M | 0 |
| Apr 29, 2025 |
10-Q filing | 679.4M shares outstanding |
680M | 0 |
| Feb 27, 2025 |
10-K filing | 652.3M shares outstanding |
650M | 0 |
| Nov 04, 2024 |
10-Q filing | 651.9M shares outstanding |
650M | 0 |
| Aug 08, 2024 |
10-Q filing | 648.2M shares outstanding |
650M | 0 |
| May 10, 2024 |
10-Q filing | 645.7M shares outstanding |
650M | 0 |
| Feb 29, 2024 |
10-K filing | 634.1M shares outstanding |
630M | 0 |
| Nov 02, 2023 |
10-Q filing | 638.2M shares outstanding |
640M | 0 |
| Aug 03, 2023 |
10-Q filing | 634.5M shares outstanding |
630M | 0 |
| May 09, 2023 |
10-Q filing | 621.5M shares outstanding |
620M | 0 |
| Mar 07, 2023 |
10-K filing | 631.9M shares outstanding |
630M | 0 |
| Nov 09, 2022 |
10-Q filing | 605.0M shares outstanding |
600M | 0 |
| Aug 09, 2022 |
10-Q filing | 484.8M shares outstanding |
480M | 0 |
| May 03, 2022 |
10-Q filing | 481.9M shares outstanding |
480M | 0 |
| Mar 03, 2022 |
10-K filing | 482.9M shares outstanding |
480M | 0 |
| Nov 09, 2021 |
10-Q filing | 475.3M shares outstanding |
480M | 0 |
| Aug 05, 2021 |
10-Q filing | 470.8M shares outstanding |
470M | 0 |
| Apr 29, 2021 |
10-Q filing | 469.5M shares outstanding |
470M | 0 |
| Mar 19, 2021 |
S-3 filing: Verona Pharma plc may offer and sell up to $250,000,000 in the aggregate of Ordinary Shares, Debt Securities, Warrants, and Units from time to time in one or more offerings. |
460M | 0 |
| Mar 19, 2021 |
POS AM filing: This is a Post-Effective Amendment to Form F-1 on Form S-3 being filed by Verona Pharma plc to convert the Registration Statement into a Registration Statement on Form S-3, and contains a prospectus relating to the resale by the selling securityholders of 355,831,184 ordinary shares that were registered under the Registration Statement. |
460M | 0 |
| Feb 25, 2021 |
10-K filing | 463.5M shares outstanding |
460M | 0 |
| Aug 17, 2020 |
F-1 filing: This F-1 filing relates to the resale of up to 355,608,968 ordinary shares by selling shareholders, including shares in the form of American Depositary Shares (ADSs). |
110M | 360M |
| Feb 27, 2020 |
20-F filing | 105.3M shares outstanding |
110M | 0 |